Comparative analysis of immune responses induced by vaccination with SIV antigens by recombinant Ad5 vector or plasmid DNA in rhesus macaques

Molecular Therapy

Volumn 18, Issue 8, 2010, Pages 1568-1576

  Hirao, Lauren A ^a   Wu, Ling ^a   Satishchandran, Abhishek ^a   Khan, Amir S ^b   Draghia Akli, Ruxandra ^b   Finnefrock, Adam C ^c   Bett, Andrew J ^c   Betts, Michael R ^a   Casimiro, Danilo R ^c   Sardesai, Niranjan Y ^b   Kim, J Joseph ^b   Shiver, John W ^a   Weiner, David B ^a,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Inovio Pharmaceuticals   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d EUROPEAN COMMISSION   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; DNA VACCINE; GAMMA INTERFERON; PEPTIDE DERIVATIVE; PLASMID DNA; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL STIMULATION; CELLULAR IMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA IMMUNIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOPHENOTYPING; MACACA; MEMORY T LYMPHOCYTE; NONHUMAN; VACCINATION; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA; MACACA; MACACA MULATTA; PRIMATES; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 77955172951     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2010.112     Document Type: Article

References (42)

1. Casimiro, DR, Chen, L, Fu, TM, Evans, RK, Caulfeld, MJ, Davies, ME et al. (2003). Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodefciency virus type 1 gag gene. J Virol 77: 6305-6313.
2. Priddy, FH, Brown, D, Kublin, J, Monahan, K, Wright, DP, Lalezari, J et al.; Merck V520-016 Study Group. (2008). Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults. Clin Infect Dis 46: 1769-1781.
3. Catanzaro, AT, Koup, RA, Roederer, M, Bailer, RT, Enama, ME, Moodie, Z et al.; Vaccine Research Center 006 Study Team. (2006). Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector. J Infect Dis 194: 1638-1649.
4. Shiver, JW, Fu, TM, Chen, L, Casimiro, DR, Davies, ME, Evans, RK et al. (2002). Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodefciency-virus immunity. Nature 415: 331-335.
5. Buchbinder, SP, Mehrotra, DV, Duerr, A, Fitzgerald, DW, Mogg, R, Li, D et al.; Step Study Protocol Team. (2008). Effcacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372: 1881-1893.
6. McElrath, MJ, De Rosa, SC, Moodie, Z, Dubey, S, Kierstead, L, Janes, H et al.; Step Study Protocol Team. (2008). HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 372: 1894-1905.
7. + T cells. Nat Med 15: 876-878.
8. O'Brien, KL, Liu, J, King, SL, Sun, YH, Schmitz, JE, Lifton, MA et al. (2009). Adenovirus-specifc immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans. Nat Med 15: 873-875.
9. Hirao, LA, Wu, L, Khan, AS, Hokey, DA, Yan, J, Dai, A et al. (2008). Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques. Vaccine 26: 3112-3120.
10. Casimiro, DR, Wang, F, Schleif, WA, Liang, X, Zhang, ZQ, Tobery, TW et al. (2005). Attenuation of simian immunodefciency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag. J Virol 79: 15547-15555.
11. + central memory T cells and survival in vaccinated SIV-challenged monkeys. Science 312: 1530-1533.
12. Santra, S, Seaman, MS, Xu, L, Barouch, DH, Lord, CI, Lifton, MA et al. (2005). Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates. J Virol 79: 6516-6522.
13. Deml, L, Bojak, A, Steck, S, Graf, M, Wild, J, Schirmbeck, R et al. (2001). Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodefciency virus type 1 Gag protein. J Virol 75: 10991-11001.
14. André, S, Seed, B, Eberle, J, Schraut, W, Bültmann, A and Haas, J (1998). Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J Virol 72: 1497-1503.
15. Schneider, R, Campbell, M, Nasioulas, G, Felber, BK and Pavlakis, GN (1997). Inactivation of the human immunodefciency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation. J Virol 71: 4892-4903.
16. Hirao, LA, Wu, L, Khan, AS, Satishchandran, A, Draghia-Akli, R and Weiner, DB (2008). Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques. Vaccine 26: 440-448.
17. Otten, G, Schaefer, M, Doe, B, Liu, H, Srivastava, I, zur Megede, J et al. (2004). Enhancement of DNA vaccine potency in rhesus macaques by electroporation. Vaccine 22: 2489-2493.
18. Otten, GR, Schaefer, M, Doe, B, Liu, H, Megede, JZ, Donnelly, J et al. (2006). Potent immunogenicity of an HIV-1 gag-pol fusion DNA vaccine delivered by in vivo electroporation. Vaccine 24: 4503-4509.
19. Luckay, A, Sidhu, MK, Kjeken, R, Megati, S, Chong, SY, Roopchand, V et al. (2007). Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specifc immune responses in rhesus macaques. J Virol 81: 5257-5269.
20. Rosati, M, Bergamaschi, C, Valentin, A, Kulkarni, V, Jalah, R, Alicea, C et al. (2009). DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge. Proc Natl Acad Sci USA 106: 15831-15836.
21. Yan, J, Hokey, DA, Morrow, M P, Corbitt, N, Harris, K, Harris, D et al. (2009). Novel SIVmac DNA vaccines encoding Env, Pol and Gag consensus proteins elicit strong cellular immune responses in cynomolgus macaques. Vaccine 27: 3260-3266.
22. Sumida, SM, Truitt, DM, Lemckert, AA, Vogels, R, Custers, JH, Addo, MM et al. (2005). Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein. J Immunol 174: 7179-7185.
23. Liu, J, Ewald, BA, Lynch, DM, Denholtz, M, Abbink, P, Lemckert, AA et al. (2008). Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys. J Virol 82: 4844-4852.
24. Liu, J, O'Brien, KL, Lynch, DM, Simmons, NL, La Porte, A, Riggs, AM et al. (2009). Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 457: 87-91.
25. Kannanganat, S, Kapogiannis, BG, Ibegbu, C, Chennareddi, L, Goepfert, P, Robinson, HL et al. (2007). Human immunodefciency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines. J Virol 81: 12071-12076.
26. + CD4 T cell responses is associated with nonprogression in HIV-1 infection. J Immunol 169: 6376-6385.
27. Emu, B, Sinclair, E, Favre, D, Moretto, WJ, Hsue, P, Hoh, R et al. (2005). Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodefciency virus replication in individuals with and without antiretroviral treatment. J Virol 79: 14169-14178.
28. + T cells. Blood 107: 4781-4789.
29. + T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 3: 1061-1068.
30. Cox, KS, Clair, JH, Prokop, MT, Sykes, KJ, Dubey, SA, Shiver, JW et al. (2008). DNA gag/adenovirus type 5 (Ad5) gag and Ad5 gag/Ad5 gag vaccines induce distinct T-cell response profles. J Virol 82: 8161-8171.
31. Lathe, R (1985). Synthetic oligonucleotide probes deduced from amino acid sequence data. Theoretical and practical considerations. J Mol Biol 183: 1-12.
32. Korber, B, Kuiken, C, Foley, B, Hahn, B, McCutchan, F, Mellors, J et al. (1998). Human Retroviruses and AIDS. Los Alamos National Laboratory: Los Alamos, NM.
33. Larder, BA, Purifoy, DJ, Powell, KL and Darby, G (1987). Site-specifc mutagenesis of AIDS virus reverse transcriptase. Nature 327: 716-717.
34. Larder, BA, Kemp, SD and Purifoy, DJ (1989). Infectious potential of human immunodefciency virus type 1 reverse transcriptase mutants with altered inhibitor sensitivity. Proc Natl Acad Sci USA 86: 4803-4807.
35. Davies, JF 2nd, Hostomska, Z, Hostomsky, Z, Jordan, SR and Matthews, DA (1991). Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase. Science 252: 88-95.
36. Schatz, O, Cromme, FV, Grüninger-Leitch, F and Le Grice, SF (1989). Point mutations in conserved amino acid residues within the C-terminal domain of HIV-1 reverse transcriptase specifcally repress RNase H function. FEBS Lett 257: 311-314.
37. Mizrahi, V, Usdin, MT, Harington, A and Dudding, LR (1990). Site-directed mutagenesis of the conserved Asp-443 and Asp-498 carboxy-terminal residues of HIV-1 reverse transcriptase. Nucleic Acids Res 18: 5359-5363.
38. Leavitt, AD, Shiue, L and Varmus, HE (1993). Site-directed mutagenesis of HIV-1 integrase demonstrates differential effects on integrase functions in vitro. J Biol Chem 268: 2113-2119.
39. Wiskerchen, M and Muesing, MA (1995). Human immunodefciency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells. J Virol 69: 376-386.
40. Youil, R, Toner, TJ, Su, Q, Casimiro, D, Shiver, JW, Chen, L et al. (2003). Comparative analysis of the effects of packaging signal, transgene orientation, promoters, polyadenylation signals, and E3 region on growth properties of frst-generation adenoviruses. Hum Gene Ther 14: 1017-1034.
41. Chapman, BS, Thayer, RM, Vincent, KA and Haigwood, NL (1991). Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. Nucleic Acids Res 19: 3979-3986.
42. Goodwin, EC and Rottman, FM (1992). The 3'-fanking sequence of the bovine growth hormone gene contains novel elements required for effcient and accurate polyadenylation. J Biol Chem 267: 16330-16334.